サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1528051

核医学イメージング装置の世界市場

Nuclear Medicine Imaging Equipment

出版日
ページ情報
英文 267 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
核医学イメージング装置の世界市場
出版日: 2024年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 267 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

核医学イメージング装置の世界市場は2030年までに45億米ドルに達する見込み

2023年に31億米ドルと推定される核医学イメージング装置の世界市場は、2030年には45億米ドルに達し、分析期間2023-2030年のCAGRは5.7%で成長すると予測されます。本レポートで分析したセグメントの1つである単一光子放出コンピュータ断層撮影（SPECT）システムは、CAGR 6.1％を記録し、分析期間終了までに22億米ドルに達すると予測されます。ハイブリッド陽電子放出断層撮影（PET）システム分野の成長率は、分析期間中CAGR 5.8％と推定されます。

米国市場は8億1,010万米ドル、中国はCAGR 8.7％で成長予測

米国の核医学イメージング装置市場は、2023年に8億1,010万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 8.7%で推移し、2030年には10億米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4%と4.6%と予測されています。欧州では、ドイツがCAGR 4.2%で成長すると予測されています。

世界の核医学イメージング装置市場- 主要動向と促進要因のまとめ

現代のヘルスケアにおいて核医学イメージング装置が不可欠な理由とは？

核医学イメージング装置は、正確な診断や治療計画に不可欠な体内構造や機能の詳細な画像を提供することで、現代のヘルスケアにおいて重要な役割を果たしています。陽電子放射断層撮影（PET）スキャナーや単光子放射断層撮影（SPECT）システムなどのこれらの装置は、少量の放射性物質を利用して生理学的プロセスを可視化します。これにより、がん、心血管疾患、神経疾患などの病気の早期発見が可能になります。他の画像診断法とは異なり、核医学技術は組織や臓器の解剖学的側面と機能的側面の両方を評価することができ、効果的な治療戦略を立てるために不可欠な包括的洞察を提供します。分子レベルでの異常を検出する核医学画像の能力は、しばしば早期診断につながります。

技術の進歩はどのように核医学イメージング装置を形成しているか？

技術の進歩は、核医学イメージング装置の能力と応用を著しく向上させています。固体検出器の開発などの検出器技術の革新は、画像の解像度と感度を向上させ、より精密で正確なイメージングを可能にしました。PET/CTやSPECT/CTのようなハイブリッドイメージング技術の統合は、核医学の機能的イメージング能力とコンピュータ断層撮影（CT）の解剖学的詳細さを融合させ、より包括的な診断ツールを提供します。さらに、画像処理ソフトウェアと人工知能（AI）の進歩により、画像解析と解釈が合理化され、より迅速で正確なものとなっています。このような技術的改良は、核医学画像の診断精度を高めるだけでなく、患者固有の疾患プロファイルに関する詳細な洞察に基づいて治療を調整する個別化医療での利用も拡大しています。

核医学画像診断の新たな動向とイノベーションとは？

核医学イメージング市場には、その様相を一変させるようないくつかの新たな動向と革新が見られます。顕著な動向の1つは、診断と治療の両方に使用される放射性同位元素を含む薬剤である放射性医薬品の使用の増加です。新しい放射性医薬品の開発により、さまざまな種類のがんや慢性疾患など、核医学で診断・治療できる疾患の範囲が広がっています。もう一つの大きな動向は、従来のアナログシステムに比べて画質が向上し、スキャン時間が短縮されたデジタルPETおよびSPECTシステムの採用が拡大していることです。分子イメージングの台頭も注目に値します。分子イメージングは生体内の細胞や分子のプロセスを可視化し、より精密で的を絞った治療への道を開く。さらに、核医学イメージングと磁気共鳴イメージング（MRI）などの他の診断モダリティとの統合により、患者の健康状態をより総合的に把握できるマルチモダル・イメージング・プラットフォームが構築されつつあります。

核医学イメージング装置市場の成長を促進する要因は？

核医学イメージング装置市場の成長は、いくつかの要因によってもたらされます。第一に、がんや心血管障害などの慢性疾患の有病率の増加が、早期かつ正確な発見を可能にする高度な診断ツールに対する需要を煽っています。ハイブリッド・イメージング・システムの開発や画像解析におけるAIの統合を含む技術の進歩は、核医学イメージングをより効率的で利用しやすいものにしています。診断と治療の両方の用途で放射性医薬品の使用が拡大していることも、核医学の範囲を広げる重要な促進要因となっています。さらに、個別化医療が重視されるようになったことで、疾患の分子的・機能的側面に関する詳細な洞察を提供する核医学イメージング技術の採用が進んでいます。規制当局の支援と有利な償還政策は、これらの高度なイメージング技術をヘルスケアプロバイダーや患者がより利用しやすくすることで、市場の成長を促進しています。最後に、ヘルスケア・インフラへの投資の増加と核医学画像診断の利点に関する意識の高まりが市場の拡大をさらに後押ししており、これらの高度診断ツールが現代のヘルスケアにおいて重要な役割を果たし続けています。

調査対象企業の例（全29件）

  • Digirad Corporation
  • GE Healthcare
  • Mediso Medical Imaging Systems
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-1228

Global Nuclear Medicine Imaging Equipment Market to Reach US$4.5 Billion by 2030

The global market for Nuclear Medicine Imaging Equipment estimated at US$3.1 Billion in the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Single-Photon Emission Computed Tomography (SPECT) Systems, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Hybrid Positron Emission Tomography (PET) Systems segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$810.1 Million While China is Forecast to Grow at 8.7% CAGR

The Nuclear Medicine Imaging Equipment market in the U.S. is estimated at US$810.1 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Nuclear Medicine Imaging Equipment Market - Key Trends and Drivers Summarized

Why Is Nuclear Medicine Imaging Equipment Essential in Modern Healthcare?

Nuclear medicine imaging equipment plays a crucial role in contemporary healthcare by providing detailed images of the body’s internal structures and functions, which are vital for accurate diagnosis and treatment planning. These devices, such as positron emission tomography (PET) scanners and single-photon emission computed tomography (SPECT) systems, utilize small amounts of radioactive materials to visualize physiological processes. This allows for the early detection of diseases, including cancer, cardiovascular diseases, and neurological disorders. Unlike other imaging modalities, nuclear medicine techniques can assess both the anatomical and functional aspects of tissues and organs, providing comprehensive insights that are essential for formulating effective treatment strategies. The ability of nuclear medicine imaging to detect abnormalities at the molecular level often leads to earlier diagnosis, which is critical for improving patient outcomes and managing diseases more effectively.

How Are Technological Advancements Shaping Nuclear Medicine Imaging Equipment?

Technological advancements are significantly enhancing the capabilities and applications of nuclear medicine imaging equipment. Innovations in detector technology, such as the development of solid-state detectors, have improved image resolution and sensitivity, enabling more precise and accurate imaging. The integration of hybrid imaging technologies, such as PET/CT and SPECT/CT, combines the functional imaging capabilities of nuclear medicine with the anatomical detail of computed tomography (CT), offering a more comprehensive diagnostic tool. Furthermore, advances in image processing software and artificial intelligence (AI) are streamlining image analysis and interpretation, making it faster and more accurate. These technological improvements not only enhance the diagnostic accuracy of nuclear medicine imaging but also expand its use in personalized medicine, where treatments are tailored based on detailed insights into the patient’s specific disease profile.

What Are the Emerging Trends and Innovations in Nuclear Medicine Imaging?

The nuclear medicine imaging market is witnessing several emerging trends and innovations that are poised to transform its landscape. One prominent trend is the increasing use of radiopharmaceuticals, which are drugs that contain radioactive isotopes used in both diagnosis and treatment. The development of new radiopharmaceuticals is expanding the range of conditions that can be diagnosed and treated with nuclear medicine, including various types of cancer and chronic diseases. Another significant trend is the growing adoption of digital PET and SPECT systems, which offer enhanced image quality and reduced scan times compared to traditional analog systems. The rise of molecular imaging is also noteworthy, as it allows for the visualization of cellular and molecular processes in living organisms, paving the way for more precise and targeted therapies. Additionally, the integration of nuclear medicine imaging with other diagnostic modalities, such as magnetic resonance imaging (MRI), is creating multi-modal imaging platforms that provide a more holistic view of the patient’s health.

What Factors Are Driving the Growth in the Nuclear Medicine Imaging Equipment Market?

The growth in the nuclear medicine imaging equipment market is driven by several factors. Firstly, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, is fueling the demand for advanced diagnostic tools that can provide early and accurate detection. Technological advancements, including the development of hybrid imaging systems and the integration of AI in image analysis, are making nuclear medicine imaging more efficient and accessible. The expanding use of radiopharmaceuticals in both diagnostic and therapeutic applications is also a significant driver, as it broadens the scope of nuclear medicine. Additionally, the rising emphasis on personalized medicine is driving the adoption of nuclear imaging techniques that offer detailed insights into the molecular and functional aspects of diseases. Regulatory support and favorable reimbursement policies are facilitating market growth by making these advanced imaging technologies more accessible to healthcare providers and patients. Lastly, increasing investments in healthcare infrastructure and the growing awareness about the benefits of nuclear medicine imaging are further propelling the market’s expansion, ensuring that these advanced diagnostic tools continue to play a vital role in modern healthcare.

Select Competitors (Total 29 Featured) -

  • Digirad Corporation
  • GE Healthcare
  • Mediso Medical Imaging Systems
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Nuclear Medicine Imaging Equipment - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Spurs Growth in Nuclear Medicine Imaging Equipment Market
    • Technological Advancements in Detector Technology Propel Market Expansion
    • Development of New Radiopharmaceuticals Expands Addressable Market Opportunity
    • Hybrid Imaging Technologies Strengthens Business Case for Integrated Diagnostic Solutions
    • Adoption of Digital PET and SPECT Systems Drives Market Growth
    • Growing Focus on Molecular Imaging Generates Demand for Advanced Nuclear Medicine Equipment
    • Integration with AI and Image Processing Software Enhances Diagnostic Accuracy and Drives Adoption
    • Increasing Awareness and Acceptance of Nuclear Medicine Imaging Drives Adoption
    • Emerging Applications in Oncology and Cardiology Sustain Growth in Market Demand
    • Advances in Non-Invasive Imaging Technologies Propel Growth in Diagnostic Capabilities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Nuclear Medicine Imaging Equipment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Single-Photon Emission Computed Tomography (SPECT) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Planar Scintigraphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Planar Scintigraphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Planar Scintigraphy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • JAPAN
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • CHINA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • EUROPE
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • FRANCE
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • GERMANY
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Spain 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Russia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of Europe 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Australia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • INDIA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: India 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: South Korea 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Argentina 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Brazil 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Mexico 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Latin America 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Nuclear Medicine Imaging Equipment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Iran 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Israel 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Saudi Arabia 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UAE 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Rest of Middle East 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030
  • AFRICA
    • Nuclear Medicine Imaging Equipment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Nuclear Medicine Imaging Equipment by Product Type - Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Africa 16-Year Perspective for Nuclear Medicine Imaging Equipment by Product Type - Percentage Breakdown of Value Sales for Single-Photon Emission Computed Tomography (SPECT) Systems, Hybrid Positron Emission Tomography (PET) Systems and Planar Scintigraphy for the Years 2014, 2024 & 2030

IV. COMPETITION